Sandoz International GmbH

About Sandoz International GmbH

Sandoz International GmbH is a global leader in generic pharmaceuticals and biosimilars, dedicated to providing high-quality, affordable medicines to patients worldwide. With a strong commitment to innovation and sustainability, Sandoz aims to improve access to healthcare by developing a diverse portfolio of products that meet the needs of various therapeutic areas.

Founded as a subsidiary of Novartis, Sandoz has established itself as a trusted name in the pharmaceutical industry. The company operates in over 140 countries, leveraging its extensive research and development capabilities to bring new treatments to market efficiently.

Core Activities:

• Development and manufacturing of generic medications
• Production of biosimilars that replicate the efficacy of original biologic drugs
• Investment in research to enhance drug formulations and delivery methods
• Collaboration with healthcare professionals to ensure optimal patient outcomes

Sandoz is committed to maintaining the highest standards of quality and compliance, ensuring that all products meet rigorous regulatory requirements. The company’s vision is to be the leading provider of high-quality generics and biosimilars, making healthcare accessible to all.

Through its dedication to corporate social responsibility, Sandoz actively engages in initiatives that promote health education and disease prevention in underserved communities. By prioritizing sustainability, Sandoz strives to minimize its environmental impact while maximizing the positive effects of its products on public health.

In summary, Sandoz International GmbH stands at the forefront of the pharmaceutical industry, driven by a mission to enhance patient care through innovative solutions and a commitment to affordability.